Additionally, another study suggested that increased lipocalin-2 levels related to NAFLD may induce the breakdown of the blood–brain barrier and increase the levels of inflammatory cytokines in the brain (Mondal et al., 2020). This evidence concerns the gene LCN2 and metabolic dysfunction-associated steatotic liver disease.